BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Expression Profiles of Breast Tumors from Singapore and Europe

Dataset: Expression Profiles of Breast Tumors from Singapore and Europe

To facilitate a better understanding of the molecular heterogeneity of breast cancer and to uncover gene-survival associations that...

Registered by ArrayExpress Uploader
View Dataset

To facilitate a better understanding of the molecular heterogeneity of breast cancer and to uncover gene-survival associations that segregate with distinct molecular subtypes, we recently compiled a meta-analytical database of over 2,000 human breast tumor expression profiles variously annotated for clinical and pathological variables and derived from various institutions worldwide. This database was utilized for the breast tumor study cited below: Nagalla, et. al., Genome Biology, 2013. While the majority of the tumor expression profiles included in this database derived from publicly accessible microarray repositories, a number of the samples had not been previously published. Here, we describe the origin of these samples and provide their associated clinical and pathological annotations with the hope that other investigators will be able to utilize these data in their own research. Breast tumor samples derived from the Institut Jules Bordet (IJB; Belgium), John Radcliffe Hospital (JRH; Oxford) and the National University Hospital (NUH, Singapore) were profiled on the Affymetrix U133A platform. The number of tumors profiled (n) and the corresponding dates of tumor diagnosis are as follows. IJB: n=41, 1994-2001; JRH: n=8, 1990-1993; and NUH: n=100, 2000-2002.

Species:
human

Samples:
139

Source:
E-GEOD-45255

Updated:
Dec.12, 2014

Registered:
Jun.18, 2014


Factors: (via ArrayExpress)
Sample DMFS EVENT DEFINED AS DISTANT METASTASIS OR DEATH FROM BREAST CANCER HER2 STATUS PATIENT AGE CHARACTERISTICS HISTOLOGICAL GRADE SIZE MM LN STATUS TREATMENT TYPE DFS TIME DSS TIME DMFS TIME PGR STATUS YES DSS EVENT DEFINED AS DEATH FROM BREAST CANCER ER STATUS DFS EVENT DEFINED AS ANY TYPE OF RECURRENCE OR DEATH FROM BREAST CANCER HISTOLOGY
GSM1100175 not specified NA 43 endocrine? (0=no, 1=yes): 0 G1 21 LN- none 9.42 NA 9.419 NA not specified NA ER+ not specified NA
GSM1100174 not specified NA 37 endocrine? (0=no, 1=yes): 0 G2 23 LN- none 10.61 NA 10.614 NA not specified NA ER- 1 NA
GSM1100173 1 NA 67 endocrine? (0=no, 1=yes): 0 NA 10 LN- none 7.15 NA 7.151 NA not specified NA ER- 1 NA
GSM1100172 not specified He- 50 endocrine? (0=no, 1=yes): 0 G3 29 LN- CMFx6 NA 1.66027397260274 1.66 PgR- 1 not specified ER- NA NA
GSM110017 not specified He- 72 endocrine? (0=no, 1=yes): 1 G2 20 LN- tamoxifen NA 4.50958904109589 4.51 PgR- 1 not specified ER+ NA NA
GSM1100170 not specified He+ 56 endocrine? (0=no, 1=yes): 1 G1 30 LN- tamoxifen NA 3.92602739726027 3.93 PgR+ 1 not specified ER+ NA NA
GSM1100169 not specified He- 46 endocrine? (0=no, 1=yes): 1 G3 27 LN- CMFx6; Tamoxifen NA 4.95890410958904 4.96 PgR- 1 not specified ER- NA NA
GSM1100168 not specified He+ 45 endocrine? (0=no, 1=yes): 1 G2 30 LN- tamoxifen NA 4.56164383561644 4.56 PgR+ 1 not specified ER+ NA NA
GSM1100167 not specified He+ 48 endocrine? (0=no, 1=yes): 0 G3 60 LN- CMFx6 NA 5.00821917808219 5.01 PgR- 1 not specified ER- NA NA
GSM1100166 not specified He- 45 endocrine? (0=no, 1=yes): 0 G2 20 LN- CMFx6 NA 4.64383561643836 4.64 PgR+ 1 not specified ER+ NA NA
GSM1100165 not specified He- 70 endocrine? (0=no, 1=yes): 1 G2 20 LN- tamoxifen NA 5.13424657534247 5.13 PgR- 1 not specified ER+ NA NA
GSM1100164 not specified NA 59 endocrine? (0=no, 1=yes): 0 G3 45 LN- ACx4 NA 6.25753424657534 6.26 PgR- 1 not specified ER- NA NA
GSM1100163 not specified He- 61 endocrine? (0=no, 1=yes): 1 G3 14 LN- CMFx6; Arimidex/Tamoxifen NA 5.56712328767123 5.57 PgR- 1 not specified ER- NA NA
GSM1100162 not specified He- 60 endocrine? (0=no, 1=yes): 1 G3 20 LN- ACx4; Arimidex/Tamoxifen NA 5.10958904109589 5.11 PgR+ 1 not specified ER+ NA NA
GSM110016 not specified He- 53 endocrine? (0=no, 1=yes): 1 G3 19 LN- tamoxifen NA 5.52328767123288 5.52 PgR+ 1 not specified ER+ NA NA
GSM1100160 not specified He- 42 endocrine? (0=no, 1=yes): 0 G2 14 LN- CMFx6 NA 6.69315068493151 6.69 PgR+ 1 not specified ER+ NA NA
GSM1100159 not specified He- 73 endocrine? (0=no, 1=yes): NA NA 38 LN- NA NA 6.18630136986301 6.19 PgR- NA not specified ER- NA NA
GSM1100158 not specified NA 46 endocrine? (0=no, 1=yes): 1 G3 32 LN- CMFx6; Tamoxifen NA 2.57260273972603 2.57 NA 1 not specified NA NA NA
GSM1100157 not specified He+ 57 endocrine? (0=no, 1=yes): 1 G1 20 LN- tamoxifen NA 3.11506849315069 3.12 PgR- 1 not specified ER+ NA NA
GSM1100156 not specified He- 66 endocrine? (0=no, 1=yes): 1 G1 27 LN- tamoxifen NA 5.93698630136986 5.94 PgR+ 1 not specified ER+ NA NA
GSM1100155 not specified He+ 62 endocrine? (0=no, 1=yes): 1 G3 27 LN- tamoxifen NA 6.12876712328767 6.13 PgR+ 1 not specified ER+ NA NA
GSM1100154 not specified He- 67 endocrine? (0=no, 1=yes): 1 G3 40 LN- ACx6; Tamoxifen NA 6.61369863013699 6.61 PgR- 1 not specified ER- NA NA
GSM1100153 not specified He+ 70 endocrine? (0=no, 1=yes): 1 G2 35 LN- tamoxifen NA 6.65205479452055 6.65 PgR- 1 not specified ER+ NA NA
GSM1100152 not specified He+ 77 endocrine? (0=no, 1=yes): 1 G2 15 LN- tamoxifen NA 6.17534246575342 6.18 PgR+ 1 not specified ER+ NA NA
GSM110015 not specified He+ 52 endocrine? (0=no, 1=yes): 1 G2 20 LN- ACx4; Tamoxifen NA 6.01917808219178 6.02 PgR- 1 not specified ER- NA NA
GSM1100150 not specified He+ 81 endocrine? (0=no, 1=yes): 1 G2 20 LN- tamoxifen NA 7.57260273972603 7.57 PgR- 1 not specified ER+ NA NA
GSM1100149 not specified He- 55 endocrine? (0=no, 1=yes): 1 G3 18 LN- tamoxifen NA 7.30684931506849 7.31 PgR+ 1 not specified ER+ NA NA
GSM1100148 not specified He+ 48 endocrine? (0=no, 1=yes): 1 G2 12 LN- Tamoxifen+Zoledronic acid NA 7.85479452054795 7.85 NA 1 not specified ER+ NA NA
GSM1100147 not specified He- 54 endocrine? (0=no, 1=yes): 1 G2 10 LN- tamoxifen NA 7.82191780821918 7.82 PgR- 1 not specified ER- NA NA
GSM1100146 1 He+ 72 endocrine? (0=no, 1=yes): 1 G3 37 LN- Arimidex/Tamoxifen NA 5.16438356164384 3.30 PgR+ 1 not specified ER+ NA NA
GSM1100145 1 He- 60 endocrine? (0=no, 1=yes): 1 G3 40 LN- CMFx2; Tamoxifen NA 6.75068493150685 3.65 PgR+ 1 not specified ER+ NA NA
GSM1100144 1 He- 54 endocrine? (0=no, 1=yes): 0 G1 55 LN- ACx4 NA 8.02191780821918 6.15 PgR- 1 not specified ER+ NA NA
GSM1100143 1 He- 36 endocrine? (0=no, 1=yes): 1 G2 13 LN- Tamoxifen+Zoledronic acid NA 7.07945205479452 2.42 PgR- 1 not specified ER- NA NA
GSM1100142 not specified He- 46 endocrine? (0=no, 1=yes): 1 G1 10 LN- Tamoxifen+Zoledronic acid NA 2.18904109589041 2.18 PgR- 1 not specified ER+ NA NA
GSM110014 1 He+ 70 endocrine? (0=no, 1=yes): 1 G3 35 LN- tamoxifen NA 0.991780821917808 0.76 PgR+ 1 1 ER+ NA NA
GSM1100140 1 He- 73 endocrine? (0=no, 1=yes): 0 G3 34 LN- ACx3/CMFx1 NA 4.62191780821918 3.80 PgR- 1 1 ER- NA NA
GSM1100139 1 He- 63 endocrine? (0=no, 1=yes): 1 G3 46 LN- tamoxifen NA 4.92876712328767 2.21 PgR+ 1 1 ER+ NA NA
GSM1100138 1 He- 38 endocrine? (0=no, 1=yes): 1 G3 32 LN- ECx4; Tamoxifen NA 2.75342465753425 1.35 PgR- 1 1 ER+ NA NA
GSM1100137 1 He+ 57 endocrine? (0=no, 1=yes): 1 NA 85 LN- tamoxifen NA 5.03561643835616 0.25 PgR+ 1 1 ER+ NA NA
GSM1100136 1 He- 68 endocrine? (0=no, 1=yes): 1 G3 17 LN- tamoxifen NA 6.17260273972603 4.51 PgR+ 1 1 ER+ NA NA
GSM1100135 1 He- 66 endocrine? (0=no, 1=yes): 1 G3 21 LN- tamoxifen NA 4.19452054794521 4.18 PgR- 1 1 ER- NA NA
GSM1100134 1 He+ 59 endocrine? (0=no, 1=yes): 1 G3 25 LN- tamoxifen NA 3.07945205479452 0.65 PgR- 1 1 ER- NA NA
GSM1100133 1 He+ 47 endocrine? (0=no, 1=yes): 1 G3 28 LN- CMFx6; Tamoxifen NA 2.12602739726027 1.39 PgR+ 1 1 ER+ NA NA
GSM1100132 1 He+ 63 endocrine? (0=no, 1=yes): 1 G2 30 LN- tamoxifen NA 3.44931506849315 3.05 NA 1 1 ER+ NA NA
GSM110013 not specified NA 53 endocrine? (0=no, 1=yes): 1 G3 35 LN+ Tam+CMFx6 cycles 4.33 4.33 4.33 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100130 not specified He- 59 endocrine? (0=no, 1=yes): NA G1 60 LN+ NA 4.83 4.83 4.83 PgR+ NA not specified ER+ not specified invasive ductal carcinoma
GSM1100129 not specified He- 62 endocrine? (0=no, 1=yes): 1 G3 20 LN- tamoxifen 4.38 4.38 4.38 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100128 not specified He- 43 endocrine? (0=no, 1=yes): 1 G1 24 LN+ Tam+ACx4 cycles 2.67 2.67 2.67 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100127 not specified NA 55 endocrine? (0=no, 1=yes): 0 G1 25 LN- none 4.67 4.67 4.67 NA not specified not specified NA not specified invasive ductal carcinoma and papillary carcinoma
GSM1100126 not specified He- 84 endocrine? (0=no, 1=yes): 1 G3 28 LN- tamoxifen 0.83 0.83 0.83 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100125 1 He+ 38 endocrine? (0=no, 1=yes): 1 G3 40 LN+ Tam+AC 2.00 2.00 2.00 PgR+ 1 not specified ER+ 1 invasive ductal carcinoma
GSM1100124 not specified He+ 67 endocrine? (0=no, 1=yes): 1 G3 25 LN+ tamoxifen 4.92 4.92 4.92 PgR- 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100123 not specified He- 52 endocrine? (0=no, 1=yes): 1 G1 20 LN- tamoxifen 5.17 5.17 5.17 PgR+ 1 not specified ER+ not specified invasive lobular carcinoma
GSM1100122 1 He+ 50 endocrine? (0=no, 1=yes): 1 G3 16 LN+ Tam+ACx4 cycles 3.83 5.75 3.83 PgR+ 1 not specified ER- 1 invasive ductal carcinoma
GSM110012 not specified He+ 64 endocrine? (0=no, 1=yes): 1 G3 50 LN- tamoxifen 5.21 5.21 5.21 PgR+ 1 not specified ER+ not specified medullary carcinoma
GSM1100120 not specified He- 47 endocrine? (0=no, 1=yes): 0 G3 30 LN+ CAF 4.54 4.54 4.54 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100119 not specified He+ 38 endocrine? (0=no, 1=yes): 1 G3 38 LN- Tam+ACx4 cycles 5.58 5.58 5.58 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100118 not specified He+ 58 endocrine? (0=no, 1=yes): 1 G3 51 LN+ Tam+ACx4 cycles 5.92 5.92 5.92 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100117 not specified He+ 47 endocrine? (0=no, 1=yes): 0 G3 21 LN- ACx4 cycles 5.88 5.88 5.88 PgR- 1 not specified ER- not specified invasive ductal carcinoma
GSM1100116 not specified He- 51 endocrine? (0=no, 1=yes): 1 G3 18 LN- Tam+CMFx6 cycles 5.79 5.79 5.79 PgR- 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100115 not specified He+ 48 endocrine? (0=no, 1=yes): 0 G3 35 LN- ACx4 cycles 5.83 5.83 5.83 PgR- 1 not specified ER- not specified invasive ductal carcinoma
GSM1100114 not specified He- 46 endocrine? (0=no, 1=yes): 0 G3 25 LN- ACx4 cycles 5.83 5.83 5.83 PgR- 1 not specified ER- not specified invasive ductal carcinoma
GSM1100113 not specified He+ 51 endocrine? (0=no, 1=yes): 0 G3 27 LN- ACx4 cycles 1.92 5.58 1.33 PgR- 1 not specified ER- 1 invasive ductal carcinoma
GSM1100112 not specified He- 36 endocrine? (0=no, 1=yes): 1 G3 25 LN- Tam+CMFx6 cycles 6.17 6.17 6.17 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100 not specified He+ 61 endocrine? (0=no, 1=yes): 0 G3 15 LN+ CAFx6 cycles 5.83 5.83 5.83 PgR- 1 not specified ER- not specified invasive ductal carcinoma
GSM1100110 not specified He+ 48 endocrine? (0=no, 1=yes): 0 G3 32 LN- ACx4 cycles 5.71 5.71 5.71 PgR- 1 not specified ER- not specified invasive ductal carcinoma
GSM1100109 not specified He- 61 endocrine? (0=no, 1=yes): 0 G3 25 LN+ CMF 5.88 5.88 5.88 PgR- 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100108 not specified He- 42 endocrine? (0=no, 1=yes): 0 G3 20 LN- none 1.17 6.50 1.17 PgR- not specified not specified ER- not specified medullary carcinoma
GSM1100107 not specified He- 77 endocrine? (0=no, 1=yes): 1 G1 40 LN- tamoxifen 3.50 4.33 3.50 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100106 NA He- 81 endocrine? (0=no, 1=yes): 1 G1 40 LN- tamoxifen NA NA NA PgR+ 1 NA ER+ NA papillary carcinoma
GSM1100105 not specified He+ 42 endocrine? (0=no, 1=yes): NA G3 23 LN- NA 4.00 4.00 4.00 PgR- NA not specified ER- not specified invasive ductal carcinoma
GSM1100104 1 He+ 38 endocrine? (0=no, 1=yes): 1 G3 36 LN- Tam+ACx4 cycles 2.29 2.88 2.29 PgR- 1 not specified ER+ 1 invasive ductal carcinoma
GSM1100103 1 He+ 51 endocrine? (0=no, 1=yes): 0 G3 30 LN+ ACx4 cycles 0.79 1.46 0.79 PgR- 1 not specified ER- 1 invasive ductal carcinoma
GSM1100102 not specified He- 60 endocrine? (0=no, 1=yes): 1 G1 15 LN- Tam+CMFx6 cycles 5.58 5.79 5.58 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM110010 not specified He+ 52 endocrine? (0=no, 1=yes): 1 G3 45 LN+ Tam+ACx4 cycles 6.29 6.29 6.29 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100100 not specified He- 48 endocrine? (0=no, 1=yes): 0 G3 35 LN- ACx4 cycles 0.75 0.75 0.75 PgR- 1 not specified ER- not specified invasive ductal carcinoma
GSM1100099 not specified He- 42 endocrine? (0=no, 1=yes): 0 G3 22 LN- AC 4.17 4.25 4.17 PgR- 1 not specified ER- not specified invasive ductal carcinoma
GSM1100098 not specified He- 48 endocrine? (0=no, 1=yes): 0 G3 30 LN+ ACx4 cycles 5.08 5.08 5.08 PgR- 1 not specified ER- not specified invasive ductal carcinoma
GSM1100097 not specified He+ 34 endocrine? (0=no, 1=yes): 0 G3 35 LN+ ACx8 cycles; taxol 4.38 4.38 4.38 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100096 1 He- 29 endocrine? (0=no, 1=yes): 0 G1 80 LN+ CAFx6 cycles 2.21 3.04 2.21 PgR+ 1 1 ER+ 1 invasive lobular carcinoma
GSM1100095 not specified He- 86 endocrine? (0=no, 1=yes): 1 G1 21 LN+ tamoxifen 3.13 4.38 3.13 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100094 1 He+ 54 endocrine? (0=no, 1=yes): 0 G3 35 LN+ CAF 1.29 1.38 1.29 PgR- 1 1 ER- 1 invasive ductal carcinoma
GSM1100093 1 He+ 46 endocrine? (0=no, 1=yes): NA G3 22 LN+ NA 0.13 0.38 0.13 PgR- NA 1 ER- 1 invasive ductal carcinoma
GSM1100092 not specified He- 41 endocrine? (0=no, 1=yes): 0 G3 40 LN- ACx4 cycles 5.54 5.54 5.54 PgR- 1 not specified ER- not specified invasive ductal carcinoma
GSM110009 1 He- 80 endocrine? (0=no, 1=yes): 1 G3 40 LN+ tamoxifen 1.96 1.96 1.96 PgR+ 1 not specified ER+ 1 invasive ductal carcinoma
GSM1100090 not specified He+ 45 endocrine? (0=no, 1=yes): 0 G3 20 LN+ CAF 4.83 4.83 4.83 PgR- 1 not specified ER- not specified invasive ductal carcinoma
GSM1100089 not specified He+ 64 endocrine? (0=no, 1=yes): 0 G3 30 LN- ACx4 cycles 5.08 5.08 5.08 PgR- 1 not specified ER- not specified invasive ductal carcinoma
GSM1100088 1 He+ 62 endocrine? (0=no, 1=yes): 0 G3 35 LN+ none 0.88 1.00 0.88 PgR- not specified not specified ER- 1 invasive ductal carcinoma
GSM1100087 1 He+ 62 endocrine? (0=no, 1=yes): 1 G3 25 LN+ Arimidex+CMFx2 cycles 0.00 2.08 0.00 PgR+ 1 1 ER+ 1 invasive ductal carcinoma
GSM1100086 not specified He+ 58 endocrine? (0=no, 1=yes): 0 G3 30 LN+ CAF 1.96 1.96 1.96 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100085 not specified He+ 45 endocrine? (0=no, 1=yes): 0 G3 25 LN+ AC 5.25 5.29 5.25 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100084 1 He+ 54 endocrine? (0=no, 1=yes): 0 G3 20 LN+ ACx4 cycles 3.96 4.63 3.96 PgR- 1 1 ER- 1 invasive ductal carcinoma
GSM1100083 not specified NA 44 endocrine? (0=no, 1=yes): 0 G3 50 LN+ ACx4 cycles 4.00 4.00 4.00 PgR- 1 not specified ER- not specified invasive ductal carcinoma
GSM1100082 1 He+ 74 endocrine? (0=no, 1=yes): 1 G3 30 LN+ tamoxifen 2.04 2.25 2.04 PgR- 1 1 ER+ 1 invasive ductal carcinoma
GSM110008 not specified He+ 52 endocrine? (0=no, 1=yes): 0 G3 35 LN+ ACx4 cycles 4.00 4.33 4.00 PgR- 1 not specified ER- not specified invasive lobular carcinoma
GSM1100080 not specified He+ 55 endocrine? (0=no, 1=yes): 0 G3 60 LN- ACx4 cycles 1.00 5.00 1.00 PgR- 1 not specified ER- not specified invasive ductal carcinoma
GSM1100079 not specified He- 66 endocrine? (0=no, 1=yes): 1 G1 38 LN- tamoxifen NA 0.13 0.13 PgR+ 1 not specified ER+ not specified mucinous carcinoma
GSM1100078 not specified He- 47 endocrine? (0=no, 1=yes): 0 G3 32 LN+ CAF 4.88 4.88 4.88 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100077 not specified He+ 55 endocrine? (0=no, 1=yes): 1 G3 20 LN- tamoxifen 4.46 4.46 4.46 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100076 not specified He- 45 endocrine? (0=no, 1=yes): 1 G1 15 LN- tamoxifen;goserelin 5.46 5.46 5.46 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100075 not specified He+ 34 endocrine? (0=no, 1=yes): 0 G3 40 LN- ACx4 cycles 1.54 5.46 1.54 PgR- 1 not specified ER- not specified invasive ductal carcinoma
GSM1100074 not specified He- 47 endocrine? (0=no, 1=yes): 0 G2 35 LN- ACx4 cycles 5.00 5.00 5.00 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100073 not specified He- 49 endocrine? (0=no, 1=yes): 1 G2 15 LN- tamoxifen 5.33 5.33 5.33 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100072 not specified He- 64 endocrine? (0=no, 1=yes): 1 G2 12 LN- tamoxifen 5.58 5.58 5.58 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM110007 NA He+ 66 endocrine? (0=no, 1=yes): NA G2 17 LN- NA NA 0.08 NA PgR+ NA not specified ER+ NA invasive ductal carcinoma
GSM1100070 not specified He- 46 endocrine? (0=no, 1=yes): NA G2 40 LN+ NA 4.00 4.50 4.00 PgR+ NA not specified ER- not specified invasive ductal and lobular carcinoma
GSM1100069 not specified He- 73 endocrine? (0=no, 1=yes): 1 G2 20 LN+ tamoxifen 4.83 4.92 4.83 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100068 not specified He- 46 endocrine? (0=no, 1=yes): 1 G2 15 LN- Tam+CMFx6 cycles 4.88 4.88 4.88 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100067 not specified He- 42 endocrine? (0=no, 1=yes): NA G2 30 LN+ NA 4.50 4.50 4.50 PgR- NA not specified ER+ not specified invasive ductal carcinoma
GSM1100066 1 He+ 46 endocrine? (0=no, 1=yes): 1 G2 60 LN+ Tam+CAFx2 cycles 1.67 1.75 1.67 PgR- 1 1 ER+ 1 invasive ductal carcinoma
GSM1100065 not specified He+ 44 endocrine? (0=no, 1=yes): 0 G2 24 LN+ none 0.42 0.42 0.42 PgR+ not specified not specified ER+ not specified invasive ductal carcinoma
GSM1100064 not specified He- 55 endocrine? (0=no, 1=yes): 1 G2 19 LN+ tamoxifen 4.92 4.92 4.92 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100063 not specified He+ 57 endocrine? (0=no, 1=yes): 1 G2 21 LN- tamoxifen 4.75 4.75 4.75 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100062 not specified He- 40 endocrine? (0=no, 1=yes): 0 G2 23 LN+ CAF 5.17 5.17 5.17 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM110006 not specified He- 44 endocrine? (0=no, 1=yes): 0 G2 35 LN- CMF 4.67 4.67 4.67 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100060 not specified He+ 46 endocrine? (0=no, 1=yes): 0 G2 30 LN+ CAF 5.67 5.67 5.67 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100059 not specified He- 35 endocrine? (0=no, 1=yes): 1 G2 40 LN- Tam+ACx4 cycles 4.67 4.67 4.67 PgR+ 1 not specified ER- not specified invasive ductal carcinoma
GSM1100058 not specified He- 55 endocrine? (0=no, 1=yes): 0 G2 15 LN- none 1.25 4.58 0.67 PgR+ not specified not specified ER+ 1 invasive ductal carcinoma
GSM1100057 1 He+ 67 endocrine? (0=no, 1=yes): 0 G2 25 LN- none 2.83 2.83 2.83 PgR- not specified not specified ER- 1 invasive ductal carcinoma
GSM1100056 not specified He+ 75 endocrine? (0=no, 1=yes): 1 G2 40 LN+ tamoxifen 0.92 5.42 0.67 PgR+ 1 not specified ER- 1 invasive ductal carcinoma
GSM1100055 1 He- 48 endocrine? (0=no, 1=yes): 0 G2 15 LN- anastrozole;taxol 0.04 3.08 0.04 PgR- 1 1 ER+ 1 invasive lobular carcinoma
GSM1100054 not specified He+ 49 endocrine? (0=no, 1=yes): 1 G2 23 LN+ Tam+CAFx6 cycles 5.25 5.25 5.25 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100053 not specified He- 69 endocrine? (0=no, 1=yes): 0 G2 25 LN+ CAF 5.00 5.00 5.00 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100052 NA He+ 51 endocrine? (0=no, 1=yes): 1 G2 25 LN+ Tam+ACx8;taxol NA NA NA PgR- 1 NA ER+ NA invasive ductal carcinoma
GSM110005 not specified He- 60 endocrine? (0=no, 1=yes): 1 G2 20 LN- Tam+CMFx6 cycles 6.33 6.33 6.33 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100050 not specified He+ 77 endocrine? (0=no, 1=yes): 1 G2 35 LN- tamoxifen 5.58 5.58 5.58 PgR- 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100049 not specified He- 53 endocrine? (0=no, 1=yes): 0 G2 22 LN+ CMF 5.75 5.92 5.75 PgR+ 1 not specified ER- not specified invasive ductal carcinoma
GSM1100048 not specified He- 50 endocrine? (0=no, 1=yes): 0 G2 25 LN+ CAF 5.83 5.83 5.83 PgR+ 1 not specified ER- not specified invasive ductal carcinoma
GSM1100047 not specified He- 52 endocrine? (0=no, 1=yes): 0 G2 18 LN- CMF 5.79 5.79 5.79 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100046 not specified He- 53 endocrine? (0=no, 1=yes): 1 G2 18 LN- tamoxifen 6.00 6.00 6.00 PgR- 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100045 not specified He+ 46 endocrine? (0=no, 1=yes): 0 G2 15 LN- none 4.04 4.08 4.04 PgR- not specified not specified ER- not specified invasive ductal carcinoma
GSM1100044 not specified He+ 48 endocrine? (0=no, 1=yes): NA G2 20 LN- NA 5.63 5.63 5.63 PgR+ NA not specified ER+ not specified invasive ductal carcinoma
GSM1100043 1 He+ 54 endocrine? (0=no, 1=yes): 0 G2 60 LN+ ACx4 cycles 2.00 2.25 2.00 PgR- 1 not specified ER- 1 invasive ductal carcinoma
GSM1100042 not specified He+ 69 endocrine? (0=no, 1=yes): 1 G2 25 LN- tamoxifen 6.25 6.25 6.25 PgR- 1 not specified ER+ not specified invasive ductal carcinoma
GSM110004 not specified He+ 40 endocrine? (0=no, 1=yes): 1 G2 25 LN- Tam+CMFx6 cycles 2.63 2.63 2.63 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100040 not specified He- 69 endocrine? (0=no, 1=yes): 1 G2 35 LN- tamoxifen 5.88 6.04 5.88 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100039 not specified He- 69 endocrine? (0=no, 1=yes): 1 G2 30 LN- tamoxifen 4.29 4.29 4.29 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100038 1 He+ 62 endocrine? (0=no, 1=yes): 0 G2 30 LN+ ACx4 cycles 1.13 1.13 1.13 PgR- 1 not specified ER- 1 invasive ductal carcinoma
GSM1100037 not specified He- 41 endocrine? (0=no, 1=yes): 1 G2 20 LN- Tam+ACx4 cycles 6.17 6.17 6.17 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma

Tags

  • breast
  • breast cancer
  • cancer
  • genome

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2026 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use